Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients
Condition(s):Type 2 Diabetes MellitusLast Updated:October 16, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Type 2 Diabetes MellitusLast Updated:October 16, 2013Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:January 3, 2014Completed
Condition(s):Polycystic Ovary SyndromeLast Updated:November 12, 2019Completed
Condition(s):Menstrual Irregularities; HyperandrogenismLast Updated:November 29, 2018Unknown status
Condition(s):Type 2 Diabetes MellitusLast Updated:May 9, 2012Completed
Condition(s):Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)Last Updated:June 23, 2017Completed
Condition(s):Polycystic Ovary Syndrome; InfertilityLast Updated:July 28, 2015Completed
Condition(s):Insulin SensitivityLast Updated:October 8, 2020Withdrawn
Condition(s):Polycystic Ovary Syndrome; InfertilityLast Updated:October 20, 2015Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:January 26, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.